We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVOG icon
2626
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.72B
$509K ﹤0.01%
7,262
+490
+7% +$33.7K
JPUS
2627
JPMorgan Diversified Return US Equity ETF
JPUS
$464M
$509K ﹤0.01%
6,801
-1,803
-21% -$133K
AEL
2628
DELISTED
American Equity Investment Life Holding Company
AEL
$509K ﹤0.01%
18,740
-364
-2% -$10.4K
ZAYO
2629
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$508K ﹤0.01%
15,437
-24,002
-61% -$766K
HYEM icon
2630
VanEck Emerging Markets High Yield Bond ETF
HYEM
$526M
$506K ﹤0.01%
21,208
+2,744
+15% +$64.2K
CCEC
2631
Capital Clean Energy Carriers
CCEC
$1.34B
$506K ﹤0.01%
48,202
+12,740
+36% +$135K
PTCT icon
2632
PTC Therapeutics
PTCT
$6.21B
$505K ﹤0.01%
11,222
+3,837
+52% +$152K
ERTH icon
2633
Invesco MSCI Sustainable Future ETF
ERTH
$136M
$504K ﹤0.01%
11,063
-255
-2% -$11.2K
BRSL
2634
Brightstar Lottery PLC
BRSL
$2.03B
$502K ﹤0.01%
38,733
-173,656
-82% -$2.36M
KBWD icon
2635
Invesco KBW High Dividend Yield Financial ETF
KBWD
$425M
$501K ﹤0.01%
23,368
+1,525
+7% +$32.9K
LOR
2636
DELISTED
Lazard World Dividend & Income Fund, Inc.
LOR
$500K ﹤0.01%
50,287
-25,276
-33% -$247K
DTH icon
2637
WisdomTree International High Dividend Fund
DTH
$661M
$499K ﹤0.01%
12,360
+211
+2% +$8.51K
NXR
2638
DELISTED
NUVEEN ELECT TAX-FREE INC 3
NXR
$499K ﹤0.01%
32,287
-5,706
-15% -$86.4K
FHB icon
2639
First Hawaiian
FHB
$3.34B
$497K ﹤0.01%
19,204
+2,369
+14% +$62.7K
FRME icon
2640
First Merchants
FRME
$2.68B
$497K ﹤0.01%
13,123
-4,777
-27% -$175K
ONEQ icon
2641
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$497K ﹤0.01%
15,790
-1,110
-7% -$34.3K
HZO icon
2642
MarineMax
HZO
$1.15B
$496K ﹤0.01%
30,199
-7,325
-20% -$127K
HYLV
2643
DELISTED
IQ S&P High Yield Low Volatility Bond ETF
HYLV
$496K ﹤0.01%
19,757
+311
+2% +$7.68K
CIM
2644
Chimera Investment
CIM
$994M
$495K ﹤0.01%
8,744
+318
+4% +$18K
IDA icon
2645
Idacorp
IDA
$8.11B
$494K ﹤0.01%
4,917
+491
+11% +$49.5K
SMAR
2646
DELISTED
Smartsheet Inc.
SMAR
$494K ﹤0.01%
+10,200
New +$433K
EVI icon
2647
EVI Industries
EVI
$183M
$493K ﹤0.01%
12,874
+374
+3% +$13.8K
PSL icon
2648
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$83.4M
$491K ﹤0.01%
6,822
QCRH icon
2649
QCR Holdings
QCRH
$1.71B
$491K ﹤0.01%
14,080
CMPR icon
2650
Cimpress
CMPR
$2.32B
$490K ﹤0.01%
5,389
+515
+11% +$46.3K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.